About this Webinar:
This session, ‘Using Artificial Intelligence (AI) to support Quantitative Digital Pathology in R&D’, was live on Wednesday 17th November 2021. You can re-watch the full webinar including the Q&A above.
Presented by OracleBio’s Chief Scientific Officer, Lorcan Sherry, it covered:
- Using AI Deep Learning to improve image analysis accuracy and turn-around time in a pre-clinical tumor IHC study
- Integrating clinical pathologist input in development and validation of a Deep Learning Tissue Classifier App
- Advantages of implementing Deep Learning for tissue segmentation and cell detection in multiplex IF studies
- and more…
Chief Scientific Officer
As co-founder and Chief Scientific Officer at OracleBio, Lorcan has helped establish the company as a market leader within its field, supporting the digital pathology programmes of major Pharma and Biotech companies around the globe.
Day to day, Lorcan oversees a team of image analysis scientists and pathologists responsible for the execution of Client image analysis R&D studies, while further driving the adoption of innovative techniques and processes to improve the quality and efficiency of our services.
More from OracleBio:
Comparative multiplex digital phenotyping of the tumour microenvironment across multiple tumour types using a well characterized multi-tumour tissue microarray
OracleBio 8-plex TMA analysis data is presented at the AACR Virtual Annual Meeting in April 2021 and the Digital Pathology & AI Congress: Europe in December 2021. The poster, produced in collaboration with Ultivue and TriStar Technology Group, focuses on the...
High Throughput Tissue Imaging and Phenotyping by Streamlined 8-plex Staining and Analysis of Complex TMA Samples
OracleBio 8-plex TMA analysis data is presented at the Society for the Immunotherapy of Cancer (SITC) Virtual Annual Meeting in November 2020. The poster, produced in collaboration with Ultivue and TriStar Technology Group, focuses on the analysis of multi-tumour...
Utilizing Image Analysis to Characterize an 8-plex Immunofluorescence Immune Checkpoint Biomarker Panel within the Tumor Tissue Microenvironment
OracleBio presented a poster on quantitative analysis of an 8-plex Immunofluorescence panel at the AACR 2020 Virtual Annual Meeting. The poster, produced in collaboration with Ultivue, focuses on the analysis of an immune checkpoint biomarker panel in NSCLC and CRC...
Find out more about our Multiplex IF Analysis
OracleBio's Quantitative Digital Pathology Services
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more